BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Operating income as a percentage of revenue
Latest
38.98%
↑ 118% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
-221.41%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 38.98% | +7008.2% |
| 2024 | -0.56% | +98.2% |
| 2023 | -31.29% | +42.9% |
| 2022 | -54.81% | +51.5% |
| 2021 | -113.08% | +88.5% |
| 2020 | -981.12% | -381.8% |
| 2019 | -203.66% | +55.4% |
| 2018 | -456.20% | -100.1% |
| 2017 | -227.95% | -23.6% |
| 2016 | -184.45% | - |